In a sup­ply chain short­age workaround, Aus­trali­a's Vic­to­ria state aims to build its own mR­NA fa­cil­i­ty

As coun­tries all around the world have ex­pe­ri­enced trou­bles with vac­cine short­ages, Aus­tralia’s Vic­to­ria state is de­vel­op­ing its own mR­NA man­u­fac­tur­ing fa­cil­i­ty in an ef­fort to up its num­ber of vac­ci­nat­ed res­i­dents.

Vic­to­ria will spend $39 mil­lion to set up the fa­cil­i­ty, which could be the first in the south­ern hemi­sphere, Reuters re­port­ed. The mR­NA tech­nol­o­gy is used in the Pfiz­er-BioN­Tech and Mod­er­na vac­cines, and has got­ten more at­ten­tion, as ade­n­ovirus-based vac­cines from As­traZeneca and J&J have had re­ports of rare, but sim­i­lar blood clots in some pa­tients. There have been no re­ports of ma­jor side ef­fects in ei­ther Mod­er­na or Pfiz­er’s jab.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER